Tech Company Financing Transactions

Xencor Funding Round

On 10/25/2007, Xencor raised $15 million in Series E funding from Merlin BioMed Group, Novo Ventures and Oxford Bioscience Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

111 West Lemon Ave.
Monrovia, CA 91016
USA

Phone

(626) 305-5900

Website

www.xencor.com

Email Address

[email protected]

Overview

In collaboration with our partners -- including leading biotechnology company Genentech and pharmaceutical company Eli Lilly -- we are selectively designing next-generation protein drug candidates with improved selectivity, efficacy and safety.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Bassil Dahiyat

        

Chief Medical Officer

Paul Foster

        

VP - Finance

John Kuch

        

VP - R & D

John Desjarlais

        

Browse more venture capital transactions:

Prev: 10/25/2007: EchoSign venture capital transaction
Next: 10/26/2007: Arteriocyte venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary